Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Director | Common Stock | 1.91K | $535K | $280.00 | Jun 25, 2024 | Direct |
AVEO PHARMACEUTICALS, INC. | Director | Common Stock | 375 | $5.63K | $15.00 | Jan 19, 2023 | Direct |
GENOCEA BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 15K | Jul 1, 2021 | Direct | ||
Astria Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.1K | Jun 5, 2024 | Direct | ||
MADRIGAL PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 1.11K | Jun 25, 2024 | Direct | ||
AVEO PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 0 | Jan 19, 2023 | Direct | ||
Epizyme, Inc. | Director | Common Stock, par value $0.0001 | 0 | $1.41 | Aug 12, 2022 | Direct |